ELEVATE 2 (RVT-1201-2002): A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension
Primary Objective
To evaluate the effect of rodatristat ethyl on the percent change from baseline pulmonary vascular resistance (PVR), as measured by right heart catheterization (RHC) in patients with PAH
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 21-3433
More information available at ClinicalTrials.gov: NCT04712669
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers